retatrutide peptide injection What to Know About Weight-Loss Drug| RealSelf News Retatrutide: breakthrough… or still too

Recent clinical reviews have shown that for most patients, starting a GLP-1 medication does not significantly change INR levels

Potential side effects typically include mild digestive changes during the adjustment periodgas, bloating, and bowel habit changes that usually resolve within 1-2 weeks

Retatrutide is not approved for human use in the United Kingdom

Consult your researcher before making any dose adjustments, and review the dose schedule to understand the expected progression

The financial aspect of managing hair health during GLP-1 therapy is worth considering as well

However, GLP-1s can come with challenges, including gastrointestinal side effects, risk of micronutrient deficiencies, muscle and bone loss, poor long-term follow through with weight regain if stopped, and high costs